Hypoxic regulation and prognostic value of LAMP3 expression in breast cancer.

Abstract:

BACKGROUND:LAMP3 is a newly described hypoxia regulated gene of potential interest in hypoxia-induced therapy resistance and metastasis. The prognostic value of LAMP3 in breast cancer was investigated. METHODS:Expression levels of LAMP3 in breast cancer cell lines and patient tissues were determined by real-time polymerase chain reaction and in a tissue microarray by immunohistochemistry. Immunofluorescent staining was used to evaluate the distribution of LAMP3 in tumor xenografts relative to pimonidazole. Kaplan-Meier analysis as well as multivariate Cox regression survival analyses were performed. RESULTS:LAMP3 was variably expressed in breast cancer cell lines and induced in an oxygen concentration-dependent manner. LAMP3 protein expression colocalized with hypoxic areas in breast cancer xenografts. LAMP3 mRNA was higher in breast tumors from patients with node-positive (P = .019) and/or steroid hormone receptor-negative tumors (P < .001). Breast cancer patients with high LAMP3 mRNA levels had more locoregional recurrences (P = .032 log-rank). This was limited to patients treated with lumpectomy and radiotherapy as primary treatment (n = 53, P = .009). No association with metastasis-free survival was found. In multivariate Cox regression analysis, LAMP3 remained as a statistically independent prognostic factor for locoregional recurrence (hazard ratio, 2.76; 95% confidence interval, 1.01-7.5; P = .048) after correction for menopausal status, histologic grade, tumor size, nodal status, therapy, and steroid hormone receptor status. LAMP3 protein in breast cancer tissue proved also to be of prognostic relevance. CONCLUSIONS:Evidence was provided for an association of LAMP3 with tumor cell hypoxia in breast cancer xenografts. In the current breast cancer cohorts, LAMP3 had independent prognostic value.

journal_name

Cancer

journal_title

Cancer

authors

Nagelkerke A,Mujcic H,Bussink J,Wouters BG,van Laarhoven HW,Sweep FC,Span PN

doi

10.1002/cncr.25938

subject

Has Abstract

pub_date

2011-08-15 00:00:00

pages

3670-81

issue

16

eissn

0008-543X

issn

1097-0142

journal_volume

117

pub_type

杂志文章

相关文献

CANCER文献大全
  • Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for 1976-2000.

    abstract:BACKGROUND:Although cervical carcinoma incidence and mortality rates have declined in the U.S. greatly since the introduction of the Papanicolaou smear, this decline has not been uniform for all histologic subtypes. Therefore, the authors assessed the differential incidence rates of squamous cell carcinoma (SCC) and ad...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20064

    authors: Wang SS,Sherman ME,Hildesheim A,Lacey JV Jr,Devesa S

    更新日期:2004-03-01 00:00:00

  • Tissue diagnosis for carcinoma of the pancreas and periampullary structures.

    abstract::In a county hospital, 217 patients were operated on for suspected cancer of the pancreas (186 patients) and periampullary structures (31 patients). The surgeons' philosophy was to avoid biopsy of the pancreas whenever possible, they often performed radical resection based on clinical judgment alone (8% of the resectio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820301)49:5<1035::aid-cncr2820

    authors: Lee YT

    更新日期:1982-03-01 00:00:00

  • Two members of the SIBLING family of proteins, DSPP and BSP, may predict the transition of oral epithelial dysplasia to oral squamous cell carcinoma.

    abstract:BACKGROUND:: Patients with oral premalignant lesions (OPL) present with oral squamous cell carcinomas (OSCC) at a much higher rate than the general population. There are currently no useful markers that indicate specifically which OPLs are most likely to progress. Three small integrin binding ligands N-linked glycoprot...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24938

    authors: Ogbureke KU,Abdelsayed RA,Kushner H,Li L,Fisher LW

    更新日期:2010-04-01 00:00:00

  • Chemotherapy with mitoxantrone in combination with continuous infusion vinblastine for metastatic breast cancer.

    abstract::The efficacy of mitoxantrone in combination with vinblastine was assessed in 156 patients with metastatic breast cancer who had been treated previously with one or multiple chemotherapeutic regimens. Mitoxantrone was given by random assignment, either as a 10 mg/m2 single intravenous dose or in five consecutive daily ...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19871015)60:8<1724::aid-cncr2820

    authors: Fraschini G,Yap HY,Mann G,Buzdar AU,Blumenschein GR,Hortobagyi GN

    更新日期:1987-10-15 00:00:00

  • Case-linked analysis of clinical trial enrollment among adolescents and young adults at a National Cancer Institute-designated comprehensive cancer center.

    abstract:BACKGROUND:Poor accrual to cancer clinical trials may contribute to the lower improvement in survival observed for adolescents and young adults (AYAs) (those aged 15-39 years) with cancer. This has been difficult to quantify without reliable mechanisms to link incident cases with study enrollments. Using unique resourc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29669

    authors: Collins CL,Malvar J,Hamilton AS,Deapen DM,Freyer DR

    更新日期:2015-12-15 00:00:00

  • Tumor response and progression-free survival as potential surrogate endpoints for overall survival in extensive stage small-cell lung cancer: findings on the basis of North Central Cancer Treatment Group trials.

    abstract:BACKGROUND:The authors investigated the putative surrogate endpoints of best response, complete response (CR), confirmed response, and progression-free survival (PFS) for associations with overall survival (OS), and as possible surrogate endpoints for OS. METHODS:Individual patient data from 870 untreated extensive st...

    journal_title:Cancer

    pub_type: 杂志文章,meta分析

    doi:10.1002/cncr.25526

    authors: Foster NR,Qi Y,Shi Q,Krook JE,Kugler JW,Jett JR,Molina JR,Schild SE,Adjei AA,Mandrekar SJ

    更新日期:2011-03-15 00:00:00

  • Non-Hodgkin's lymphoma presenting with primary adrenal insufficiency. A disease with an underestimated frequency?

    abstract::Adrenal involvement in the course of a non-Hodgkin's lymphoma (NHL) appears to occur relatively often, but only seven cases of NHL-induced adrenal insufficiency were found in a recent review of the literature. The authors report four cases of hypoadrenalism in 127 patients treated for NHL; the cases were staged and cl...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19920501)69:9<2333::aid-cncr2820

    authors: Gamelin E,Beldent V,Rousselet MC,Rieux D,Rohmer V,Ifrah N,Boasson M,Bigorgne JC

    更新日期:1992-05-01 00:00:00

  • Prognostic importance of histologic grading in papillary thyroid carcinoma.

    abstract:BACKGROUND:The influence of various clinicopathologic features on survival of patients with papillary thyroid carcinoma has been examined. In particular, histologic grade, which was obtained by a combined assessment of nuclear atypia, tumor necrosis, and vascular invasion (VAN score) was studied. According to this, his...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19931101)72:9<2680::aid-cncr2820

    authors: Akslen LA

    更新日期:1993-11-01 00:00:00

  • Barriers to health care contribute to delays in follow-up among women with abnormal cancer screening: Data from the Patient Navigation Research Program.

    abstract:BACKGROUND:There is limited understanding of the association between barriers to care and clinical outcomes within patient navigation programs. METHODS:Secondary analyses of data from the intervention arms of the Patient Navigation Research Program were performed, which included navigated participants with abnormal br...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.29607

    authors: Ramachandran A,Snyder FR,Katz ML,Darnell JS,Dudley DJ,Patierno SR,Sanders MR,Valverde PA,Simon MA,Warren-Mears V,Battaglia TA,Patient Navigation Research Program Investigators.

    更新日期:2015-11-15 00:00:00

  • Cancer-associated galactosyltransferase acceptor: inhibition of transformed cell and tumor growth.

    abstract::A distinctive glycopeptide, which acts as an acceptor for a cancer-associated galactosyltransferase, has been detected in sera and effusions of patients with extensive carcinoma. Cancer-associated galactosyltransferase acceptor (CAGA) purified from human malignant effusions was tested for its effects on cell growth in...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19800315)45:5+<1212::aid-cncr282

    authors: Podolsky DK,Isselbacher KJ

    更新日期:1980-03-15 00:00:00

  • Induction paclitaxel in previously untreated, resectable, advanced squamous cell carcinomas of head and neck.

    abstract:BACKGROUND:Previous Phase II trials evaluating paclitaxel as a single agent have produced objective response rates of 38-40%. However, in these studies patients had recurrent disease and had received previous treatment with chemotherapy, radiation, surgery, or some combination of the same. To the authors' knowledge, th...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(20001215)89:12<2587::aid-cncr11>

    authors: Grecula JC,Smith RE,Rhoades CA,Sharma P,Agrawal A,Zhang H,Allen J,Goldman FP,Young D,Schuller DE

    更新日期:2000-12-15 00:00:00

  • Risk factors for intrahepatic recurrence of hepatocellular carcinoma in cirrhotic patients treated by percutaneous ethanol injection.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) complicating cirrhosis has a high intrahepatic recurrence rate after treatment by surgical resection or percutaneous ethanol injection (PEI). In this study, certain clinical, biochemical, and pathologic parameters were evaluated as risk factors for intrahepatic tumor recurrence...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19970415)79:8<1501::aid-cn

    authors: Pompili M,Rapaccini GL,de Luca F,Caturelli E,Astone A,Siena DA,Villani MR,Grattagliano A,Cedrone A,Gasbarrini G

    更新日期:1997-04-15 00:00:00

  • HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.

    abstract:BACKGROUND:Although p53 and HER-2/neu overexpression are found in 30% of breast carcinomas in women of all ages and are associated with high rates of lymph node metastases, their role in women age < 30 years has not been studied extensively. METHODS:The institutional breast cancer data base was searched to identify yo...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20850

    authors: Maru D,Middleton LP,Wang S,Valero V,Sahin A

    更新日期:2005-03-01 00:00:00

  • The past 60 years in liver surgery.

    abstract::The anniversary of the first publication of Cancer provides an opportunity to review the progress in liver cancer surgery in the past 60 years. Indeed, the past half century has been witness to remarkable advances in liver surgery that have provided benefit to so many patients afflicted with primary or secondary liver...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.23652

    authors: Tanabe KK

    更新日期:2008-10-01 00:00:00

  • Vinblastine, adriamycin, thiotepa, and halotestin (VATH): therapy for advanced breast cancer refractory to prior chemotherapy.

    abstract::Nineteen postmenopausal patients with metastatic breast cancer refractory to conventional combination chemotherapy were treated with monthly cycles with the combinations of vinblastine, adriamycin, thiotepa and halotestin. Ten patients (52%) responded with a greater than 50% regression of measurable tumor. The median ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197812)42:6<2534::aid-cncr282042

    authors: Perloff M,Hart RD,Holland JF

    更新日期:1978-12-01 00:00:00

  • Spontaneous regression of hepatocellular carcinoma: a case study.

    abstract::A Chinese patient with documented hepatocellular carcinoma (HCC) satisfied the criteria of Everson and Cole for spontaneous regression of malignant tumors. Subsequently he survived a tumor-free period of at least 13 years. During the period of regression, shrinkage of liver coincided with a rise of SGOT to a level com...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820715)50:2<332::aid-cncr28205

    authors: Lam KC,Ho JC,Yeung RT

    更新日期:1982-07-15 00:00:00

  • A pilot study of transcatheter arterial interferon embolization for patients with hepatocellular carcinoma.

    abstract:BACKGROUND:Systemic, high-dose interferon-alpha treatment given three times per week subcutaneously induces tumor regression in approximately 30% of patients with inoperable hepatocellular carcinoma (HCC). The objective of the current study was to determine the efficacy and safety of transcatheter arterial interferon e...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11400

    authors: Yuen MF,Ooi CG,Hui CK,Wong WM,Wong BC,Chan AO,Lai CL

    更新日期:2003-06-01 00:00:00

  • Vincristine, dactinomycin, and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group Study (a final report).

    abstract::Seventy-six patients with malignant germ cell tumors of the ovary received vincristine, dactinomycin, and cyclophosphamide (VAC) postoperatively. Fifty-four were treated after removal of all gross disease. The majority of these remain disease-free. Indeed, only 15 (28%) have failed, including 11 of 24 with pure endode...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19850715)56:2<243::aid-cncr28205

    authors: Slayton RE,Park RC,Silverberg SG,Shingleton H,Creasman WT,Blessing JA

    更新日期:1985-07-15 00:00:00

  • Clinical experience with leucovorin and 5-fluorouracil.

    abstract::Two trials of leucovorin (LV) and 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer were done, both using a 3-day loading dose and then weekly doses to minimize toxicity. The first trial used LV administered by intravenous infusion with a constant dose of 5-FU 400 mg/m2, and the second trail used ora...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19890315)63:6+<1031::aid-cncr282

    authors: Laufman LR,Brenckman WD Jr,Stydnicki KA,Morgan ED,Collier M,Knick VB,Duch DS,Mullin R,Ferone R

    更新日期:1989-03-15 00:00:00

  • Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.

    abstract:BACKGROUND:The goal of the current study was to define the clinical features and outcome of recurrent osteosarcoma (OS) in children and young adults initially treated with contemporary chemotherapy. METHODS:The authors reviewed the clinical features, therapy, and outcome for 59 patients from the Mayo Clinic (Rochester...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11799

    authors: Hawkins DS,Arndt CA

    更新日期:2003-12-01 00:00:00

  • Efficacy of prolonged intermittent therapy with combined 5-FU and methyl-CCNU following resection for gastric carcinoma. A Veterans Administration Surgical Oncology, Group report.

    abstract::This prospective evaluation of 5-fluorouracil (5-FU) and methyl-CCNU administered in combination to patients with surgery for histologically proved gastric adenocarcinoma is based upon 312 patients randomized between August 1974 and May 1980. Patients were stratified into three categories of resectability, (1) complet...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1002/1097-0142(19830915)52:6<1105::aid-cncr2820

    authors: Higgins GA,Amadeo JH,Smith DE,Humphrey EW,Keehn RJ

    更新日期:1983-09-15 00:00:00

  • High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

    abstract:BACKGROUND:In this report, the authors describe their collective experience with melphalan-based autotransplants since the inception of their program at the University of Arkansas for Medical Sciences in 1989. METHODS:The authors evaluated the clinical outcomes of 3077 successive patients with multiple myeloma (MM) wh...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23327

    authors: Pineda-Roman M,Barlogie B,Anaissie E,Zangari M,Bolejack V,van Rhee F,Tricot G,Crowley J

    更新日期:2008-04-15 00:00:00

  • Increasing incidence of rectal cancer in patients aged younger than 40 years: an analysis of the surveillance, epidemiology, and end results database.

    abstract:BACKGROUND:The incidence of rectal cancer in the United States in young patients is considered to be low. Underestimating this incidence may result in a failure to diagnose younger patients with rectal cancer in a timely manner. METHODS:The authors conducted a retrospective cohort study using Surveillance, Epidemiolog...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25432

    authors: Meyer JE,Narang T,Schnoll-Sussman FH,Pochapin MB,Christos PJ,Sherr DL

    更新日期:2010-09-15 00:00:00

  • Inhibits of of colon carcinogenesis.

    abstract::Disulfiram (tetraethylthiuram disulfide, Antabuse) and sodium diethyldithiocarbamate, when added to the diet, inhibit 1,2-dimethylhydrazine (DMH)-induced neoplasia of the large bowel in female CF1 mice. Ethylene bis(dithiocarbamato)manganese (Maneb) and bis(ethylxanthogen), two pesticides with structural similarities ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197711)40:5+<2432::aid-cncr28204

    authors: Wattenberg LW,Lam LK,Fladmoe AV,Borchert P

    更新日期:1977-11-01 00:00:00

  • A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.

    abstract:BACKGROUND:The delayed effects (12-16 hours) of transdermal fentanyl make dose titration difficult during acute exacerbations of cancer pain. Patients at the authors' institution routinely are switched from transdermal to intravenous (IV) fentanyl using a 1:1 (transdermal:IV) conversion during severe episodes of pain. ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.11457

    authors: Kornick CA,Santiago-Palma J,Schulman G,O'Brien PC,Weigand S,Payne R,Manfredi PL

    更新日期:2003-06-15 00:00:00

  • A Phase I-II study of sequential administration of topotecan and oral etoposide (toposiomerase I and II inhibitors) in the treatment of patients with small cell lung carcinoma.

    abstract:BACKGROUND:Topotecan (9-dimethylaminomethyl-10-hydroxycampthothecin) is a new topoisomerase I inhibitor with promising efficacy in the treatment of patients with small cell lung carcinoma (SCLC). Combination with a topoisomerase II inhibitor may potentate the therapeutic effect of topotecan, although there has been con...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.10836

    authors: Mok TS,Wong H,Zee B,Yu KH,Leung TW,Lee TW,Yim A,Chan AT,Yeo W,Chak K,Johnson P

    更新日期:2002-10-01 00:00:00

  • Scar carcinomas of the lung in a histoplasmosis endemic area.

    abstract::Seventeen cases of pulmonary scar carcinomas were found in 112 surgically resected pulmonary carcinomas from 1985 through 1988 in a hospital situated in a histoplasmosis endemic area. These carcinomas can be divided into two types: Type I, mucinous; and Type II, non-mucinous (Clara cell). Each type of carcinoma consti...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19900101)65:1<164::aid-cncr28206

    authors: Yoneda K

    更新日期:1990-01-01 00:00:00

  • Carcinoma cuniculatum (verrucous carcinoma of the skin): a clinicopathologic study of 46 cases with ultrastructural observations.

    abstract::Forty-six examples of carcinoma cuniculatum, a rare variant of squamous cell carcinoma of the skin, were studied by means of light and electron microscopy and immunoperoxidase techniques. The tumors usually presented as ulcerated, fungating, and polypoid masses with openings of sinus tracts onto the skin surface that ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19820601)49:11<2395::aid-cncr282

    authors: Kao GF,Graham JH,Helwig EB

    更新日期:1982-06-01 00:00:00

  • Progress report of a randomized trial comparing long-term survival and late toxicity of concurrent chemoradiotherapy with adjuvant chemotherapy versus radiotherapy alone in patients with stage III to IVB nasopharyngeal carcinoma from endemic regions of Ch

    abstract:BACKGROUND:The objective of this study was to evaluate the long-term survival and late toxicities of concurrent-adjuvant chemotherapy in patients with stage III through IVB nasopharyngeal carcinoma (NPC) from endemic regions of China. METHODS:Patients with stage III to IVB NPC were assigned randomly to receive radioth...

    journal_title:Cancer

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/cncr.28049

    authors: Chen Y,Sun Y,Liang SB,Zong JF,Li WF,Chen M,Chen L,Mao YP,Tang LL,Guo Y,Lin AH,Liu MZ,Ma J

    更新日期:2013-06-15 00:00:00

  • Predictors of radiation response in lung cancer. A clinico-pathobiological analysis.

    abstract::From February 1972 to July 1975, 200 lung cancer patients were seen at the University of Rochester Cancer Center's Division of Radiation Oncology; 40% had squamous cell tumors and 87.5% had advanced disease localized to the thorax. Of the 160 patients who completed treatment, 101 were treated with continuous therapy s...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(197606)37:6<2636::aid-cncr282037

    authors: Salazar OM,Rubin P,Brown JC,Feldstein ML,Keller BE

    更新日期:1976-06-01 00:00:00